[{"Assets_0_FY_USD":"773855000.0","CIK":"1737287","CommonStockDividendsPerShareDeclared_4_FY_USD":"0.0","CommonStockSharesIssued_0_FY_shares":"121482671.0","CommonStockSharesOutstanding_0_FY_shares":"121482671.0","Country":"United States","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":"-44653000.0","NetIncomeLoss_1_FY_USD":"-30509000.0","NetIncomeLoss_4_FY_USD":"-211505000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_4_FY_USD":"-211505000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_FY_USD":"703164000.0","Ticker":"ALLO","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":"28948386.0","filed":"20190308","footnote":null,"form":"10-K","fp":"FY","fy":"2018.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20181231","qtrs":"0","uom":"USD"}]